A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10) (NCT03721341)
SABR-COMET 10
This trial is No longer recruiting
Registration number NCT03721341
Program & service
This trial is being run with the Cancer service, and as part of the Radiation Oncology program.
Trial phase
Phase 3
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Associate Professor Sashendra Senthi
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.